Cleveland BioLabs
CBLI
#10386
Rank
HK$0.38 B
Marketcap
HK$24.87
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -HK$21.36 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are HK$0.63 Million. In 2020 the company made an earning of -HK$20.15 Million a decrease over its 2019 earnings that were of -HK$18.52 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$21.36 Million6%
2020-HK$20.15 Million8.8%
2019-HK$18.52 Million-50.81%
2018-HK$37.66 Million-14.3%
2017-HK$43.94 Million-11.88%
2016-HK$49.86 Million-50.9%
2015-HK$0.11 Billion-10.24%
2014-HK$0.12 Billion-37.5%
2013-HK$0.19 Billion-23.2%
2012-HK$0.24 Billion19.68%
2011-HK$0.2 Billion133.81%
2010-HK$84.23 Million68.22%
2009-HK$50.08 Million-55.51%
2008-HK$0.12 Billion-45.62%
2007-HK$0.21 Billion255.63%
2006-HK$58.2 Million198.18%
2005-HK$19.52 Million-1.25%
2004-HK$19.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$123.81 B-573,529.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$244.15 B-1,130,865.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.28 B-330,229.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.07 B-278,331.17%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$75.28 B-348,757.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.53 B-363,812.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$91.81 Million 325.20%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.8 Billion 8,217.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA